Details

NameSymbolSector
CAPLIN POINT LABORATORIES LTD.CAPLIPOINTPharmaceuticals
Open
2830
High
2850.4
Low
2747.1
Close
2770.1
Volume
127691
Exchange
nse
Time
08-Sep-2026

Outlook

Score:

2

Rating:

RISKY

Candlestick Pattern

CandlepatternofCaplinPointLaboratoriesis
None
EstimatedStoplossofCaplinPointLaboratoriesis
2850.4
CaplinPointLaboratorieshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofCaplinPointLaboratoriesis
Unpredictableℹ
.

Trend

CaplinPointLaboratoriesisin
Sideways trendℹ
.
PriceofCaplinPointLaboratoriesis
Upℹ
by

7.24

%.
Target
Buy@

2061.62

Sell@

2919.58

Current@

2770.1

Volume

ThetradevolumesofCaplinPointLaboratorieshavebecome
Deficientℹ
ThoughthevolumetrendforCaplinPointLaboratoriesappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofCaplinPointLaboratoriesis

Down

by

34.71

%

Valuation

ThecurrentmarketpriceofCaplinPointLaboratoriesis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth3207crandtotalassetsworth3207cr,thebalancesheetofCaplinPointLaboratoriesis:
Balancedℹ
.
Cashflow
CaplinPointLaboratorieshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 60cr

.Itis
Upℹ
by

253.85

%.
53.66% i.e. ₹ 432cr earned in operatingℹ
41.49% i.e. ₹ 334cr spent in investingℹ
4.72% i.e. ₹ 38cr spent in financingℹ
0.12% i.e. ₹ 1cr earned in otherℹ
CaplinPointLaboratorieshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 39cr

.Itis
Downℹ
by

250

%.
47.04% i.e. ₹ 318cr earned in operatingℹ
47.34% i.e. ₹ 320cr spent in investingℹ
5.62% i.e. ₹ 38cr spent in financingℹ
0% in otherℹ
Income
TheincomeofCaplinPointLaboratoriesis

₹ 564cr

and

Profit

is:

₹ 160cr

CaplinPointLaboratoriesProfitisupby:

6.67

%andIncomeisUpby:

5.82

%
TheincomeofCaplinPointLaboratoriesis

₹ 533cr

and

Profit

is:

₹ 150cr

CaplinPointLaboratoriesProfitisupby:

3.45

%andIncomeisUpby:

0.95

%
TheincomeofCaplinPointLaboratoriesis

₹ 528cr

and

Profit

is:

₹ 145cr

CaplinPointLaboratoriesProfitisupby:

3.57

%andIncomeisUpby:

0.76

%
By using this site you agree to the use of cookies to deliver a better site experience.